Severe Asthma

Nicholas Kenyon, Nizar N. Jarjour

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Severe asthma is a term that is commonly used to describe patients with refractory, brittle, near fatal, and difficult-to-control asthma. Patients with severe asthma typically experience persistent symptoms despite medical therapy, report decreased quality of life and suffer an accelerated loss of lung function. The role of genetics, environmental exposure, and infection in the development of more severe asthma is the focus of ongoing research. While pathologic changes in these patients are now believed to involve lung parenchyma, in addition to large and small airways, the independent contribution of each of these compartments to the severe asthma phenotype is not well defined. The clinical evaluation of severe asthma patients should include investigating conditions commonly associated with severe asthma, such as gastroesophageal reflux disease, vocal cord dysfunction, and rhinosinusitis. In addition, advanced imaging techniques, measurement of exhaled gas or sputum indices, and airway biopsy are tools that may aid in evaluating severe asthma patients in the near future. Management of patients with severe asthma requires a comprehensive approach that includes non-pharmacological and pharmacological measures. Combination antiinflammatory and long-acting bronchodilator therapy remains the mainstay of management.

Original languageEnglish (US)
Pages (from-to)131-149
Number of pages19
JournalClinical Reviews in Allergy and Immunology
Volume25
Issue number2
DOIs
StatePublished - Oct 2003

Fingerprint

Asthma
Vocal Cord Dysfunction
Lung
Bronchodilator Agents
Environmental Exposure
Gastroesophageal Reflux
Sputum
Anti-Inflammatory Agents
Gases
Quality of Life
Pharmacology
Phenotype
Biopsy
Therapeutics
Infection
Research

Keywords

  • Chronic obstructive pulmonary disease
  • Corticosteroids
  • Refractory asthma
  • Remodeling
  • Severe asthma

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Severe Asthma. / Kenyon, Nicholas; Jarjour, Nizar N.

In: Clinical Reviews in Allergy and Immunology, Vol. 25, No. 2, 10.2003, p. 131-149.

Research output: Contribution to journalArticle

Kenyon, Nicholas ; Jarjour, Nizar N. / Severe Asthma. In: Clinical Reviews in Allergy and Immunology. 2003 ; Vol. 25, No. 2. pp. 131-149.
@article{ddf871c4c8bd4f7ab7bdcb10abe1f17d,
title = "Severe Asthma",
abstract = "Severe asthma is a term that is commonly used to describe patients with refractory, brittle, near fatal, and difficult-to-control asthma. Patients with severe asthma typically experience persistent symptoms despite medical therapy, report decreased quality of life and suffer an accelerated loss of lung function. The role of genetics, environmental exposure, and infection in the development of more severe asthma is the focus of ongoing research. While pathologic changes in these patients are now believed to involve lung parenchyma, in addition to large and small airways, the independent contribution of each of these compartments to the severe asthma phenotype is not well defined. The clinical evaluation of severe asthma patients should include investigating conditions commonly associated with severe asthma, such as gastroesophageal reflux disease, vocal cord dysfunction, and rhinosinusitis. In addition, advanced imaging techniques, measurement of exhaled gas or sputum indices, and airway biopsy are tools that may aid in evaluating severe asthma patients in the near future. Management of patients with severe asthma requires a comprehensive approach that includes non-pharmacological and pharmacological measures. Combination antiinflammatory and long-acting bronchodilator therapy remains the mainstay of management.",
keywords = "Chronic obstructive pulmonary disease, Corticosteroids, Refractory asthma, Remodeling, Severe asthma",
author = "Nicholas Kenyon and Jarjour, {Nizar N.}",
year = "2003",
month = "10",
doi = "10.1385/CRIAI:25:2:131",
language = "English (US)",
volume = "25",
pages = "131--149",
journal = "Clinical Reviews in Allergy and Immunology",
issn = "1080-0549",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - Severe Asthma

AU - Kenyon, Nicholas

AU - Jarjour, Nizar N.

PY - 2003/10

Y1 - 2003/10

N2 - Severe asthma is a term that is commonly used to describe patients with refractory, brittle, near fatal, and difficult-to-control asthma. Patients with severe asthma typically experience persistent symptoms despite medical therapy, report decreased quality of life and suffer an accelerated loss of lung function. The role of genetics, environmental exposure, and infection in the development of more severe asthma is the focus of ongoing research. While pathologic changes in these patients are now believed to involve lung parenchyma, in addition to large and small airways, the independent contribution of each of these compartments to the severe asthma phenotype is not well defined. The clinical evaluation of severe asthma patients should include investigating conditions commonly associated with severe asthma, such as gastroesophageal reflux disease, vocal cord dysfunction, and rhinosinusitis. In addition, advanced imaging techniques, measurement of exhaled gas or sputum indices, and airway biopsy are tools that may aid in evaluating severe asthma patients in the near future. Management of patients with severe asthma requires a comprehensive approach that includes non-pharmacological and pharmacological measures. Combination antiinflammatory and long-acting bronchodilator therapy remains the mainstay of management.

AB - Severe asthma is a term that is commonly used to describe patients with refractory, brittle, near fatal, and difficult-to-control asthma. Patients with severe asthma typically experience persistent symptoms despite medical therapy, report decreased quality of life and suffer an accelerated loss of lung function. The role of genetics, environmental exposure, and infection in the development of more severe asthma is the focus of ongoing research. While pathologic changes in these patients are now believed to involve lung parenchyma, in addition to large and small airways, the independent contribution of each of these compartments to the severe asthma phenotype is not well defined. The clinical evaluation of severe asthma patients should include investigating conditions commonly associated with severe asthma, such as gastroesophageal reflux disease, vocal cord dysfunction, and rhinosinusitis. In addition, advanced imaging techniques, measurement of exhaled gas or sputum indices, and airway biopsy are tools that may aid in evaluating severe asthma patients in the near future. Management of patients with severe asthma requires a comprehensive approach that includes non-pharmacological and pharmacological measures. Combination antiinflammatory and long-acting bronchodilator therapy remains the mainstay of management.

KW - Chronic obstructive pulmonary disease

KW - Corticosteroids

KW - Refractory asthma

KW - Remodeling

KW - Severe asthma

UR - http://www.scopus.com/inward/record.url?scp=0242552214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242552214&partnerID=8YFLogxK

U2 - 10.1385/CRIAI:25:2:131

DO - 10.1385/CRIAI:25:2:131

M3 - Article

C2 - 14573881

AN - SCOPUS:0242552214

VL - 25

SP - 131

EP - 149

JO - Clinical Reviews in Allergy and Immunology

JF - Clinical Reviews in Allergy and Immunology

SN - 1080-0549

IS - 2

ER -